In case you missed it: April 12 to April 16
It was a very busy week for the Contemporary OB/GYN team.
This week’s top articles included:
Dermatoses of Pregnancy
Curbside Consults delivers expert perspectives from physicians outside of the OB/GYN specialty to provide insight into various health issues affecting pregnant women.
AUGS Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder
Overactive bladder affects a significant portion of the overall population and has substantial impact on daily activities and quality of life.
ACOG Committee Opinion No. 825 advocates trauma-informed model of care
New guidance from the American College of Obstetrics and Gynecologists (ACOG) calls on ob/gyns to recognize the prevalence of trauma and its impact on patients and health care teams and outlines the importance of trauma-informed approaches to delivery of care.
FDA Approves New Oral Contraceptive Nextstellis
Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
